Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease (vol 6, pg 464, 2013)

被引：0
|
作者：
Ritz, Eberhard [1 ]
Pitt, Bertram [2 ]
机构：
[1] Heidelberg Univ, Nierenzentrum, Heidelberg, Germany
[2] Univ Michigan, Med Sch, Internal Med & Cardiovasc Dis, Ann Arbor, MI 48109 USA
来源：
CLINICAL KIDNEY JOURNAL | 2013年 / 6卷 / 06期
关键词：
D O I：
10.1093/ckj/sft143
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：674 / 674
页数：1
相关论文
共 50 条
  • [1] Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease
    Ritz, E.
    Pitt, B.
    [J]. CLINICAL KIDNEY JOURNAL, 2013, 6 (05): : 464 - 468
  • [2] Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
    Matthew J. Volk
    Andrew S. Bomback
    Philip J. Klemmer
    [J]. Current Hypertension Reports, 2011, 13 : 282 - 288
  • [3] Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
    Bomback, Andrew S.
    Klemmer, Philip J.
    [J]. BLOOD PURIFICATION, 2012, 33 (1-3) : 119 - 124
  • [4] Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
    Volk, Matthew J.
    Bomback, Andrew S.
    Klemmer, Philip J.
    [J]. CURRENT HYPERTENSION REPORTS, 2011, 13 (04) : 282 - 288
  • [5] Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
    Bertocchio, Jean-Philippe
    Warnock, David G.
    Jaisser, Frederic
    [J]. KIDNEY INTERNATIONAL, 2011, 79 (10) : 1051 - 1060
  • [6] The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges (vol 65, pg 1342, 2016)
    Yang, Pingping
    Huang, Tianlun
    Xu, Gaosi
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 82 : 124 - 124
  • [7] Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms
    Shavit, Linda
    Lifschitz, Meyer D.
    Epstein, Murray
    [J]. KIDNEY INTERNATIONAL, 2012, 81 (10) : 955 - 968
  • [8] Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker (MRB) in hypertension and chronic kidney disease
    Ningning Wan
    Asadur Rahman
    Akira Nishiyama
    [J]. Journal of Human Hypertension, 2021, 35 : 148 - 156
  • [9] Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker (MRB) in hypertension and chronic kidney disease
    Wan, Ningning
    Rahman, Asadur
    Nishiyama, Akira
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (02) : 148 - 156
  • [10] The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances
    Xinping Chen
    Xuan Li
    Kexin Zhang
    Kexin Lian
    Wenqiang Zhang
    Yixin Song
    Chengxia Kan
    Jingwen Zhang
    Fang Han
    Xiaodong Sun
    Zhentao Guo
    [J]. Clinical and Experimental Nephrology, 2024, 28 : 125 - 135
12345